Literature DB >> 23686829

Poliovirus: generation and characterization of mutants.

Cecily P Burrill1, Vanessa R Strings, Michael B Schulte, Raul Andino.   

Abstract

Poliovirus (PV) is the prototypical picornavirus. It is a non-enveloped RNA virus with a small (~7.5-kb) genome of positive polarity. cDNA clones of several strains are available, and infectious virus can be produced by the transfection of in vitro-transcribed viral genomes into an appropriate host cell. The ease of genetic studies in poliovirus is a primary reason that it has long served as a model to study RNA virus biology, pathogenesis, and evolution. Protocols for the generation and characterization of PV mutants are presented.
© 2013 by John Wiley & Sons, Inc.

Entities:  

Mesh：

Year:  2013        PMID： 23686829      PMCID： PMC4826568          DOI： 10.1002/9780471729259.mc15h02s29

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN： 1934-8525


  24 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region.

Authors:  K Bienz; D Egger; M Troxler; L Pasamontes
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  In vitro construction of poliovirus defective interfering particles.

Authors:  K Hagino-Yamagishi; A Nomoto
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

4.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

6.  An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis.

Authors:  Dorothee A Vogt; Raul Andino
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

7.  Construction and characterization of poliovirus subgenomic replicons.

Authors:  G Kaplan; V R Racaniello
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Antiviral effect of guanidine.

Authors:  W A RIGHTSEL; J R DICE; R J McALPINE; E A TIMM; I W McLEAN; G J DIXON; F M SCHABEL
Journal:  Science       Date:  1961-08-25       Impact factor: 47.728

9.  Agarose gel electrophoresis.

Authors:  D Voytas
Journal:  Curr Protoc Mol Biol       Date:  2001-05

10.  Accurate strand-specific quantification of viral RNA.

Authors:  Nicole E Plaskon; Zach N Adelman; Kevin M Myles
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240
View more
  4 in total

1.  Experimentally guided models reveal replication principles that shape the mutation distribution of RNA viruses.

Authors:  Michael B Schulte; Jeremy A Draghi; Joshua B Plotkin; Raul Andino
Journal:  Elife       Date:  2015-01-30       Impact factor: 8.140

2.  A defective viral genome strategy elicits broad protective immunity against respiratory viruses.

Authors:  Yinghong Xiao; Peter V Lidsky; Yuta Shirogane; Ranen Aviner; Chien-Ting Wu; Weiyi Li; Weihao Zheng; Dale Talbot; Adam Catching; Gilad Doitsh; Weiheng Su; Colby E Gekko; Arabinda Nayak; Joel D Ernst; Leonid Brodsky; Elia Brodsky; Elsa Rousseau; Sara Capponi; Simone Bianco; Robert Nakamura; Peter K Jackson; Judith Frydman; Raul Andino
Journal:  Cell       Date:  2021-11-18       Impact factor: 66.850

3.  Oral Vaccination Approaches for Anti-SHIV Immunity.

Authors:  Erandi Velarde de la Cruz; Lingyun Wang; Deepanwita Bose; Sailaja Gangadhara; Robert L Wilson; Rama R Amara; Pamela A Kozlowski; Anna Aldovini
Journal:  Front Immunol       Date:  2021-06-21       Impact factor: 7.561

4.  Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine.

Authors:  John O Konz; Tim Schofield; Sarah Carlyle; Rahnuma Wahid; Azeem Ansari; Jeroen R P M Strating; Ming Te Yeh; Hasmik Manukyan; Saskia L Smits; Erman Tritama; Latri Rahmah; Dori Ugiyadi; Raul Andino; Majid Laassri; Konstantin Chumakov; Andrew Macadam
Journal:  Vaccine X       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.